BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11012433)

  • 1. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies.
    Mason KP; Michna E; Zurakowski D; Koka BV; Burrows PE
    Radiology; 2000 Oct; 217(1):127-32. PubMed ID: 11012433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ethanol levels after alcohol sclerotherapy of arteriovenous malformations.
    Lee JJ; Do YS; Kim JA
    J Korean Med Sci; 2004 Feb; 19(1):51-4. PubMed ID: 14966341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure.
    Shin BS; Do YS; Lee BB; Kim DI; Chung IS; Cho HS; Kim MH; Kim GS; Kim CS; Byun HS; Shin SW; Park KB
    Radiology; 2005 Jun; 235(3):1072-7. PubMed ID: 15833991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted?
    Mitchell SE; Shah AM; Schwengel D
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):253-62. PubMed ID: 16517770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the effect of injected ethanol on pulmonary arterial pressure during sclerotherapy of arteriovenous malformations: relationship with dose of ethanol.
    Ko JS; Kim JA; Do YS; Kwon MA; Choi SJ; Gwak MS; Lee JJ; Yang M
    J Vasc Interv Radiol; 2009 Jan; 20(1):39-45; quiz 45. PubMed ID: 19028113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.
    Mason KP; Neufeld EJ; Karian VE; Zurakowski D; Koka BV; Burrows PE
    AJR Am J Roentgenol; 2001 Dec; 177(6):1359-63. PubMed ID: 11717083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period.
    Ko JS; Kim CS; Shin BS; Kim MJ; Lee JH; Kim KH; Do YS
    Clin Radiol; 2011 Jul; 66(7):639-44. PubMed ID: 21513926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for extracranial arteriovenous malformations of the head and neck.
    Jeong HS; Baek CH; Son YI; Kim TW; Lee BB; Byun HS
    Acta Otolaryngol; 2006 Mar; 126(3):295-300. PubMed ID: 16618658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.
    Goyal M; Causer PA; Armstrong D
    Radiology; 2002 Jun; 223(3):639-44. PubMed ID: 12034929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.
    Schumacher M; Dupuy P; Bartoli JM; Ernemann U; Herbreteau D; Ghienne C; Guibaud L; Loose DA; Mattassi R; Petit P; Rössler JK; Stillo F; Weber J
    Eur J Radiol; 2011 Dec; 80(3):e366-72. PubMed ID: 21458186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
    Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
    Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
    Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
    Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
    AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of venous malformations in children and implications for sclerotherapy.
    Puig S; Aref H; Chigot V; Bonin B; Brunelle F
    Pediatr Radiol; 2003 Feb; 33(2):99-103. PubMed ID: 12557065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous sclerotherapy of vascular malformations in children using sodium tetradecyl sulphate: the Birmingham experience.
    Kok K; McCafferty I; Monaghan A; Nishikawa H
    J Plast Reconstr Aesthet Surg; 2012 Nov; 65(11):1451-60. PubMed ID: 22717975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
    Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
    J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrograde transvenous ethanol embolization of high-flow peripheral arteriovenous malformations.
    van der Linden E; van Baalen JM; Pattynama PM
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):820-5. PubMed ID: 21901581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.